Literature DB >> 10753733

Risk factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996-1997.

J A Leake1, D G Mosley, B England, J V Graham, B D Plikaytis, N M Ampel, B A Perkins, R A Hajjeh.   

Abstract

Because of the increase in incidence of coccidioidomycosis among the elderly in Arizona between 1990 and 1996, a case-control study was conducted to look at risk factors for disease among these persons. Cases (n=89) were persons aged > or =60 years with laboratory-confirmed coccidioidomycosis; 2 control groups were selected, the first by use of random-digit dialing (geographic controls, n=91) and the second by use of lists of persons with negative serologic coccidioidomycosis tests (laboratory-negative controls, n=58). Elderly persons with coccidioidomycosis had spent significantly less time in Arizona than did persons in either control group and were more likely than geographic controls to have congestive heart failure or cancer, to have smoked, or to have taken corticosteroids. Elderly persons who recently have moved to Arizona or who have chronic illnesses and their physicians need to be aware of their higher risk for coccidioidomycosis in order to improve their chances of early diagnosis and treatment. These persons may benefit from vaccination, once an effective vaccine for coccidioidomycosis is developed.

Entities:  

Mesh:

Year:  2000        PMID: 10753733     DOI: 10.1086/315400

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

1.  Clinical usefulness of ELISPOT assay on pericardial fluid in a case of suspected tuberculous pericarditis.

Authors:  A Biglino; P Crivelli; E Concialdi; C Bolla; G Montrucchio
Journal:  Infection       Date:  2008-10-14       Impact factor: 3.553

Review 2.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 3.  Update on the Epidemiology of coccidioidomycosis in the United States.

Authors:  Orion Z McCotter; Kaitlin Benedict; David M Engelthaler; Ken Komatsu; Kimberley D Lucas; Janet C Mohle-Boetani; Hanna Oltean; Duc Vugia; Tom M Chiller; Gail L Sondermeyer Cooksey; Alyssa Nguyen; Chandler C Roe; Charlotte Wheeler; Rebecca Sunenshine
Journal:  Med Mycol       Date:  2019-02-01       Impact factor: 4.076

4.  Awareness and Environmental Exposures Related to Coccidioidomycosis Among Inmates at Two California Prisons, 2013.

Authors:  Kaitlin Benedict; Anne E Purfield; Janet Mohle-Boetani; Charlotte Wheeler; Benjamin J Park
Journal:  J Correct Health Care       Date:  2016-04

Review 5.  Treatment of systemic fungal infections in older patients: achieving optimal outcomes.

Authors:  C A Kauffman; S A Hedderwick
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

6.  Coccidioidomycosis Pulmonary Infection.

Authors:  Jiejian Lin; Richard J. Hamill
Journal:  Curr Infect Dis Rep       Date:  2001-06       Impact factor: 3.725

Review 7.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  In vitro whole-blood analysis of cellular immunity in patients with active coccidioidomycosis by using the antigen preparation T27K.

Authors:  Neil M Ampel; Larissa A Kramer; Lijin Li; Deborah S Carroll; Kathleen M Kerekes; Suzanne M Johnson; Demosthenes Pappagianis
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

9.  Pyo-mediastinitis: A complication of pulmonary coccidioidomycosis.

Authors:  Mohamed Y Rady; Arturo Lopez; Bhavesh M Patel; Joel S Larson
Journal:  Can J Infect Dis       Date:  2003-05

10.  Increasing incidence and severity of coccidioidomycosis at a naval air station.

Authors:  Rachel Lee; Nancy Crum-Cianflone
Journal:  Mil Med       Date:  2008-08       Impact factor: 1.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.